PSMA and Beyond 2025 CA-IX in renal cell cancer (RCC), ZIRCON, kidney cancer, stage migration for RCC, REDECT trial, renal mass biopsy, girentuximab.

Investigators compared early oncologic outcomes by staging modality among men diagnosed with very high-risk prostate cancer.

Lantheus remains strong with PYLARIFY growth, Alzheimer’s potential, and solid financials despite stock volatility and risks.

NHL free agency tracker: Bowen Byram re-signs with Sabres amidst trade speculation The NHL free agency period is still rolling ...

In partnership with Numerator, we’re tracking inflation over more than 30 essential ingredients for your daily food consumption.

PET-CT scans combine structural and functional imaging to detect diseases early. This technology improves diagnosis accuracy ...

A notable study by Bosch et al suggested that PSMA PET scanning might help identify patients with truly bone-only disease for radium therapy, potentially improving patient selection and treatment ...

This work introduces a Siamese CNN approach for lesion tracking between PET/CT scans. Our approach is applied on the laborious task of tracking a high number of bone lesions in full-body baseline and ...

Telix believes receiving a HCPCS code will support clinical adoption of Gozellix and expanded access to PSMA PET imaging. Kevin Richardson, Chief Executive Officer, Precision Medicine, Telix, said, ...

After radiolabelling with 68 Ga, Gozellix is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive ...

EP: 7. Decision-Making and Multidisciplinary Counseling for Nodal Involvement on PSMA PET EP: 8. Managing Abiraterone Intolerance: Alternative Dosing Strategies in Practice EP: 9. Incorporating ...

ArticleJuly 4, 2025 Natural Selection-Guided ACE2-Targeted Molecular Imaging: A New Paradigm for PET Tracer Development Rou Li Jie Li Shuai Xue ...